Publications by authors named "D K Induja"

Claim this Profile
A
A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated 'Orphan Drug', for the Treatment of Hepatocellular Carcinoma.
Chenicheri Kizhakkeveettil Keerthana, Sreekumar U Aiswarya, Tennyson P Rayginia, Yadu Vijayan, Shirly James, D K Induja

Anticancer Agents Med Chem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced extracellular vesicles mediated uttroside B (Utt-B) delivery to Hepatocellular carcinoma cell: Pharmacokinetics based on PBPK modelling.
Kalimuthu Kalishwaralal, Abdul Azeez Nazeer, D K Induja, Chenicheri K Keerthana, Sadiq C Shifana

Biochem Biophys Res Commun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of two new stereochemical variants of streptophenazine by cocultivation of Streptomyces NIIST-D31, Streptomyces NIIST-D47, and Streptomyces NIIST-D63 strains in C combinations.
D K Induja, A R S Jesmina, Manu M Joseph, Shanmughan Shamjith, Nagaraja Ingaladal

J Antibiot (Tokyo)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro antibacterial effects of combination of ciprofloxacin with compounds isolated from Streptomyces luteireticuli NIIST-D75.
Abdul Rasheed Safiya Jesmina, D K Induja, Thankappan Drissya, Chakiniplackal Rajan Sruthi, Kozhiparambil Gopalan Raghu

J Antibiot (Tokyo)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel aureothin diepoxide derivative from Streptomyces sp. NIIST-D31 strain.
Thankappan Drissya, D K Induja, M S Poornima, A R S Jesmina, Bernard Prabha

J Antibiot (Tokyo)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis